NYSE:SOLVMedical Equipment
Will Solventum's (SOLV) Strong Q4, 2026 Outlook and Buyback Shift Its Capital Allocation Narrative
In late February 2026, Solventum Corporation reported fourth-quarter 2025 revenue of US$1,998 million and net income of US$63 million, alongside full-year 2025 revenue of US$8.33 billion and net income of US$1.56 billion, while also announcing a US$1 billion share repurchase authorization and openness to tuck-in acquisitions.
Management highlighted portfolio optimization and capital returns as key priorities, signaling an emphasis on using the company’s healthier balance sheet and cash...